Bicara Therapeutics Inc. (BCAX)
NASDAQ:BCAX
US Market
Holding BCAX?
Track your performance easily

Bicara Therapeutics Inc. (BCAX) Income Statement

17 Followers

Bicara Therapeutics Inc. Income Statement

Last quarter (Q ), Bicara Therapeutics Inc.'s total revenue was $―, a decrease of ― from previous quarter. In Q, Bicara Therapeutics Inc.'s net income was $―. See Bicara Therapeutics Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22
Total Revenue
---
Cost of Revenue
---
Gross Profit
---
Operating Expense
-$ 39.89M$ 37.66M
Operating Income
-$ -39.89M$ -37.66M
Net Non Operating Interest Income Expense
-$ 1.31M$ -108.00K
Other Income Expense
-$ 13.40M$ 80.00K
Pretax Income
-$ -51.98M$ -37.84M
Tax Provision
-$ 5.00K$ 1.00K
Earnings From Equity Interest Net Of Tax
---
Net Income Common Stockholders
-$ -51.98M$ -37.84M
Basic EPS
-$ -89.61$ -88.20
Diluted EPS
-$ -89.61$ -88.20
Basic Average Shares
-$ 580.11K$ 429.08K
Diluted Average Shares
-$ 580.11K$ 429.08K
Dividend Per Share
---
Total Operating Income As Reported
---
Reported Normalized Basic E P S
---
Reported Normalized Diluted E P S
---
Rent Expense Supplemental
---
Total Expenses
-$ 39.89M$ 37.66M
Net Income From Continuing And Discontinued Operation
-$ -51.98M$ -37.84M
Normalized Income
-$ -38.21M$ -27.82M
Interest Expense
---
EBIT
-$ -51.98M$ -37.73M
EBITDA
-$ -51.96M$ -37.72M
Currency in USD

Bicara Therapeutics Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis